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Psychiatric research is still strongly influenced by its major classification schemes, the DSM-5 
(1) and ICD-10 (2). According to these diagnostic classification systems, psychiatric nosology is 
construed based on multinomial taxonomic distinctions, i.e., a set of putatively independent 
disorder entities that are either present or absent based on polythetic-categorical criteria. Many 
published papers in psychiatry use these dichotomous diagnoses as the main unit of analysis. 
However, as it stands, these classification systems have major limitations that substantially impede 
scientific progress (3–5). In the following, we will detail why DSM/ICD-based approaches to the 
study of mental disorders are inadequate ways to address psychopathology. We will outline the 
major limitations of categorical psychiatric diagnoses as implemented in the current classification 
systems, and then we will introduce two promising approaches that were designed to circumvent 
these caveats.
DSM AnD iCD DO nOT ADEQUATELY ASSESS 
pSYCHOpATHOLOGY
No single psychiatric diagnosis has reliably shown to represent a discrete taxa, i.e., clearly demarcated 
disorder entities that reliably delineate disorders from each other (between-disorder boundary) 
and normality from disease (within-disorder boundary) (6–10). A specific example is provided 
below. For comprehensive reviews, see, for instance, Ref. (3, 11, 12). Most evidence suggests that 
psychopathology is fully dimensional by nature, but it is worth noting that there is also some 
inconclusive support for a few discrete taxa (7, 13). Unfortunately, current psychiatric nosology as 
defined by DSM/ICD does not define distinct natural entities, and diagnoses are neither mutually 
exclusive nor exhaustive (11, 14). Therefore, boundaries between distinct diagnoses are fuzzy, there 
is significant heterogeneity within diagnoses, many patients are classified with vague “not otherwise-
specified” diagnoses, and comorbidity between putatively independent disorders is excessive 
(3, 4, 12). As it stands, psychopathology is not organized according to the DSM/ICD scheme, 
irrespective of whether assessed categorical or dimensional (15–19). Even the reliability of psy-
chiatric diagnoses, once a milestone in the development of psychiatric nosology, turned out to be 
fairly modest or even questionable for various disorders (20, 21). Fortunately, there is an easy and 
straightforward solution to that problem, as dimensional representations of mental disorders have 
shown to substantially improve reliability and validity above and beyond categorical measures (22). 
In accordance, many experts in psychiatric nosology and psychopathology now claim that our 
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current classification systems have significantly impeded further 
progress in etiological research and treatment development 
(3, 23–25).
In the following, we will briefly recapitulate some of the most 
pressing limitations underlying current nosology using the 
example of the 10 DSM-5 personality disorder (PD) diagnoses, 
as experts in PD research have repeatedly emphasized that these 
diagnostic categories are neither reliable nor valid (26–29). More 
specific, the 10 diagnoses listed in DSM-5 are arbitrary distinc-
tions without empirical foundation. There is compelling evidence 
that PD not otherwise specified is among the most prevalent 
PD diagnoses despite being conceptualized as a residual category 
(30), which stresses the inadequate coverage of diagnostic cat-
egories. Phenotypically and genetically, personality pathology 
collapses into 3–5 distinct factors, but not into the 10 DSM PD 
diagnoses (31–34). These findings stress the problem of missing 
between-disorder boundaries. Contrary to prevailing diagnostic 
criteria, these factors are not dichotomous syndromes that are 
distinct from normal personality, but dimensional continua that 
co-vary substantially with normative personality traits (33, 35, 36). 
These findings stress the issue of missing within-disorder 
boundaries (i.e., distinction between normal and pathological). 
In consequence, although both DSM and ICD state that PD 
are enduring conditions, the categorical diagnoses that they 
determine are not stable at all, which stands in sharp contrast to 
the high stability of both normative personality and dimensional 
PD traits in the very same persons (37–39).
DiMEnSiOnAL MODELS OF 
pSYCHOpATHOLOGY
Hierarchical Taxonomy of 
psychopathology (HiTOp)
The HiTOP was developed by an independent consortium of 
psychopathology researchers (24). This program was a result 
of a long-lasting dissatisfaction with the current classification 
systems and their inability to adequately model the structure 
of psychopathology. Its major objective is to provide an empiri-
cally based, fully dimensional organization of psychopathology 
by subjecting current diagnoses, syndromes, and symptoms 
to multivariate factor-analytic procedures. Recently, various 
authors have significantly advanced insights in the quantitative 
hierarchical structure of psychopathology [(15–17, 19, 40–42); 
for reviews, see Ref. (43, 44)]. HiTOP posits that psychopathol-
ogy is hierarchically structured, i.e., symptoms/signs (level 1) 
are nested within syndromes/traits (level 2) and the latter are 
nested within factors (level 3). Broad spectra are situated on top 
of the hierarchy (level 4). By this means, superordinate domains 
can account for the interdependence of lower-order structures 
such as correlated personality traits and psychopathological 
syndromes. Broad spectra at level 4 encompass internalizing 
pathology, externalizing pathology (comprising disinhibited 
and antagonistic), thought disorder (i.e., psychosis spectrum 
disorders), and detachment (i.e., pathological introversion). 
Subfactors of the internalizing spectrum at level 3 include 
sexual problems, eating pathology, fear, and distress, whereas 
subfactors of the externalizing spectrum include substance 
abuse and antisocial behavior. For more details, see Ref. (24). 
A pioneering innovation of the HiTOP is its incorporation of 
personality traits into the structure of psychopathology. This is an 
important step toward an evidence-based psychiatric nosology, 
as a compelling body of evidence has confirmed that personal-
ity substantially impacts on the occurrence, re-occurrence, and 
persistence of psychopathology (45–48), comorbidity between 
mental disorders (49–52), and, most importantly, on the liability to 
and course of broad internalizing and externalizing spectra (19, 
53–55), and the general factor of psychopathology (40, 56–58). 
Though not its main target, HiTOP can also advance research 
on genetic vulnerabilities and genetic markers, as the proposed 
hierarchical structure and correlations between its dimensions 
appear to reflect common genetic liabilities (58–63). It is further 
posited that HiTOP dimensions may show clearer and stronger 
links to neurobiological marker, that they can effectively capture 
illness course, that they account for functional impairment 
related to psychopathology, and that they may predict efficacy 
and generalizability of treatments (24).
Research Domain Criteria (RDoC)
The RDoC program was initiated by the National Institute of 
Mental Health (NIMH) due to the organization’s discontent 
with the current psychiatric classification system (64). As psy-
chiatric diagnoses do not represent valid disease entities, the 
NIMH decided to allocate its resources away from the DSM and 
toward genetic, neuroimaging, and cognitive sciences to design 
a diagnostic scheme based on neurobiological and behavioral 
phenotypes. Despite substantial efforts during the last two dec-
ades, genetic research and the neurosciences have largely failed to 
detect any reliable marker that could be applied for clinical tests 
to aid diagnosis and prognosis (23, 65). This failure is untenable 
for a specialty that contemplates a future within the clinical neu-
rosciences (66), and lack of progress was in part attributed to the 
constraints imposed by the invalid DSM/ICD-based diagnostic 
categories (3). Therefore, RDoC set out to develop a classifica-
tion system that would advance insights into the neurobiology 
of mental disorders. This system adopts a fully dimensional and 
translational scheme of mental disorders, i.e., it views psychopa-
thology in terms of deviations in fundamental functional systems. 
In contrast to the standard DSM/ICD top-down approach, which 
defines a mental disorder on the basis of signs and symptoms 
and then seeks to uncover the etiopathology underlying these 
disorders, RDoC encourages a bottom-up approach. This strategy 
involves that researcher define the normal distribution of a given 
trait or characteristic, that they examine the brain system that 
implements this function, and then which factors may account 
for dysregulation or dysfunction in these systems resulting in 
psychopathological symptoms and syndromes (65). The project 
directs research toward five neurobiological domains, specifically, 
negative valence systems, positive valence systems, cognitive 
systems, systems for social processes, and arousal/modulatory 
systems. These domains are divided into several units of analysis, 
including genes, circuits, physiology, and behavior. Each domain 
further contains several constructs. For instance, the negative 
valence systems domain involves the constructs of acute threat 
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(fear), potential threat (anxiety), sustained threat, loss, and 
frustrative non-reward (23, 65). Distinct pathophysiological 
mechanisms subsumed under the same fuzzy diagnostic DSM/
ICD-based category are seen by the pharmaceutical industry as 
a major cause of the low-response rate of psychiatric drugs (67). 
RDoC therefore constitutes a promising biological approach 
that could help to circumvent the problems associated with dia-
gnostic heterogeneity and, accordingly, the lack of pathophysi-
ological specificity within and between psychiatric diagnoses. 
As stated by Cuthbert and Insel (23), “As yet, the field of mental 
disorders research lags badly behind the rest of medicine in mov-
ing toward precision medicine” (p. 3). As a result, various phar-
maceutical companies have withdrawn their investments from 
research on new psychiatric drugs (68). The authors of RDoC 
hence legitimately claim that this neurobiological classification 
system may substantially improve etiological research, promote 
the development of new treatments, and ease the detection of 
genetic and neurobiological markers for application in diagnostic 
clinical tests (23, 64, 65). Finally, it is worth noting that RDoC 
has been criticized (69, 70), but a detailed account is beyond the 
scope of this opinion paper.
COnCLUSiOn AnD OUTLOOK
HiTOP and RDoC are recently developed dimensional frame-
works aimed at replacing the systematically flawed classification 
systems of DSM-5 and ICD-10 for research purposes. These 
two pioneering approaches are best seen as complementary 
rather than as competing systems. Both approaches have in 
common that they adopt a hierarchical, fully dimensional 
scheme. However, while HiTOP focuses exclusively on psycho-
pathological symptoms, syndromes, and broad phenomeno-
logical domains, RDoC is largely aimed at examining genetic 
and neurobiological units of analysis. Therefore, RDoC holds 
particular promise for advancing neurobiological research 
relevant to psychopathology, while HiTOP is mainly concerned 
with restructuring psychiatric nosology by providing an empiri-
cal organization of psychopathology (24). Psychiatric research 
into the epidemiology of mental disorders has long struggled 
to accurately describe the development and course of psycho-
pathology and how risk factors relate to the cooccurrence and 
stability of mental disorders due to the field’s predominant focus 
on inadequate, discrete diagnostic taxa (12, 44). With respect to 
neurobiological research, the inherent limitations of the hetero-
geneous and fuzzy DSM/ICD diagnoses were recently disclosed 
by a comprehensive meta-analysis of functional neuroimaging 
studies in patients with unipolar depression (71). In this work, 
it was demonstrated that no single pattern of aberrant brain 
activation consistently replicates across cognitive and emotional 
processing experiments. These inconsistencies may in part relate 
to inadequate statistical procedures and other methodological 
biases (72, 73), but heterogeneous clinical populations based on 
distinct neurobiological etiopathologies and symptom profiles 
are also major contributors (71). Psychiatric research must, 
therefore, abandon traditional DSM/ICD nosology and adopt 
valid and evidence-based dimensional schemes if it wants to 
advance insights into the etiology of mental disorders. Finally, 
and worthy of note, some have suggested that DSM/ICD-based 
diagnoses may have clinical utility despite their poor validity (11, 
17). However, how could a psychiatric nosology have clinical util-
ity when it impedes the development of efficacious treatments 
and clinical tests, an improved understanding of etiology and a 
reliable prediction of illness course (26, 27, 66)? Moreover, critics 
of dimensional approaches typically stress that clinical practice 
requires binary diagnoses. However, at this stage, both HiTOP 
and RDoC are merely research programs, so diagnostic entities 
are not necessary (3, 23, 24). Once dimensional concepts are 
ready for implementation in clinical practice, one could easily 
transform dimensional scores into categorical distinctions, just 
like we treat intellectual disabilities or how Peter Tyrer and the 
ICD-11 PD work group conceptualized the continuum of PD 
severity, comprising no personality disturbance, personality 
difficulties, mild PD, moderate PD, and severe PD (28). Such 
a categorical gradation considers that psychopathology is 
dimensional by nature but at the same time allows for making 
diagnoses in order to identify people who require treatment or 
disability benefits.
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